No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs555674162 |
chr16:74405881-74405882 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs187432277 |
chr16:74405894-74405895 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs542370397 |
chr16:74405908-74405909 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs370851739 |
chr16:74405965-74405966 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs559359282 |
chr16:74405986-74405987 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs528273254 |
chr16:74405991-74405992 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs11644742 |
chr16:74406010-74406011 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs551207647 |
chr16:74406017-74406018 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs571099294 |
chr16:74406018-74406019 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs530743414 |
chr16:74406043-74406044 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs11648327 |
chr16:74406047-74406048 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs567568178 |
chr16:74406051-74406052 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs570963768 |
chr16:74406052-74406053 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs567547077 |
chr16:74406076-74406077 |
Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs60816175 |
chr16:74406078-74406079 |
Weak transcription
|
CpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs138449141 |
chr16:74406094-74406095 |
Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs118022399 |
chr16:74406105-74406106 |
Weak transcription
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs373336765 |
chr16:74406184-74406185 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs575882849 |
chr16:74406237-74406238 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs538176781 |
chr16:74406299-74406300 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs74028261 |
chr16:74406311-74406312 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs573561873 |
chr16:74406332-74406333 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs542561979 |
chr16:74406337-74406338 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs558919861 |
chr16:74406342-74406343 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs112737658 |
chr16:74406369-74406370 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs60041453 |
chr16:74406373-74406374 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs544683911 |
chr16:74406382-74406383 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs564761509 |
chr16:74406423-74406424 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs546277154 |
chr16:74406465-74406466 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs371666969 |
chr16:74406466-74406467 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs192332707 |
chr16:74406510-74406511 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs529945285 |
chr16:74406514-74406515 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs372027979 |
chr16:74406520-74406521 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs201062859 |
chr16:74406527-74406528 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs112807124 |
chr16:74406541-74406542 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs539162175 |
chr16:74406545-74406546 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs564566917 |
chr16:74406550-74406551 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs569485990 |
chr16:74406555-74406556 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs538392881 |
chr16:74406570-74406571 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs370764178 |
chr16:74406631-74406632 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs554967694 |
chr16:74406655-74406656 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs4888218 |
chr16:74406694-74406695 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
43 |
rs575124219 |
chr16:74406728-74406729 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs113855713 |
chr16:74406741-74406742 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs534216191 |
chr16:74406742-74406743 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs62055180 |
chr16:74406772-74406773 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs377403506 |
chr16:74406808-74406809 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs370835499 |
chr16:74406819-74406820 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs552582998 |
chr16:74406833-74406834 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs185695986 |
chr16:74406835-74406836 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|